Item 8.01 Other Events.

Retractable Technologies, Inc. (the "Company") announces that it has been awarded a contract by the Department of Health and Human Services to supply a portion of the safety engineered syringes to be used in the United States' efforts to vaccinate the US population against the H1N1 virus (swine flu). The impact to the Company depends upon the timing and quantities of H1N1 vaccine available for US use. The program is expected to run through March 2010. The impact on the Company is uncertain, however, the Company anticipates that the related unit sales increase could be material.